Structures by: Qi J. Y.
Total: 15
C24H17Cl4N4O2Ru,(C2H6O)
C24H17Cl4N4O2Ru,(C2H6O)
Chemical Communications (Cambridge, United Kingdom) (2003) 9 1058-1059
a=16.706(2)Å b=13.6138(17)Å c=15.7145(19)Å
α=90.00° β=115.723(3)° γ=90.00°
C24H17Cl4N4O2Ru,(C2H6O)
C24H17Cl4N4O2Ru,(C2H6O)
Chemical Communications (Cambridge, United Kingdom) (2003) 9 1058-1059
a=16.706(2)Å b=13.6138(17)Å c=15.7145(19)Å
α=90.00° β=115.723(3)° γ=90.00°
N-(2-ethylbenzene)-2-indolecarboxamide
C17H16N2O,C3H7NO
Acta Crystallographica Section E (2002) 58, 8 o907-o908
a=7.8166(11)Å b=11.1683(18)Å c=11.5769(18)Å
α=73.310(3)° β=85.990(4)° γ=77.571(4)°
N,N'-Bis[2-(2-pyridyl)methyl]pyridine-2,6-dicarboxamide hemihydrate
C19H17N5O2,0.5H2O
Acta Crystallographica Section E (2002) 58, 11 o1232-o1233
a=17.784(3)Å b=17.611(3)Å c=14.217(2)Å
α=90.00° β=126.310(3)° γ=90.00°
N-(4-bromophenyl)pyridine-2-carboxamide
C12H9BrN2O
Acta Crystallographica Section E (2003) 59, 3 o374-o375
a=6.2634(11)Å b=8.2355(15)Å c=10.9828(18)Å
α=88.282(4)° β=87.215(4)° γ=78.268(3)°
N,N'-Di-4-methylphenylpyridine-2,6-dicarboxamide
C21H19N3O2
Acta Crystallographica Section E (2003) 59, 4 o415-o416
a=25.140(5)Å b=8.5779(17)Å c=8.5295(17)Å
α=90.00° β=94.46(3)° γ=90.00°
Cis-DichloroBis[N-(3-chlorophenyl)pyridine-2-carboxamide]manganese(II)
C24H18Cl4MnN4O2
Acta Crystallographica Section E (2003) 59, 11 m982-m984
a=13.181(4)Å b=9.738(3)Å c=19.707(6)Å
α=90.00° β=90.00° γ=90.00°
Tris[N-(3-chlorophenyl)pyridine-2-carboxamidato-κ^2^N,N]cobalt(III) monohydrate
C36H24Cl3CoN6O3,H2O
Acta Crystallographica Section E (2005) 61, 11 m2362-m2364
a=9.484(4)Å b=10.796(4)Å c=18.716(8)Å
α=102.378(7)° β=93.416(7)° γ=113.011(8)°
(R)-N-(1-Phenylethyl)quinoline-2-carboxamide
C18H16N2O
Acta Crystallographica Section E (2001) 57, 10 o971-o972
a=5.5955(11)Å b=10.684(2)Å c=12.224(2)Å
α=90.00° β=98.687(4)° γ=90.00°
N,N'-Di-2-methoxyphenylpyridine-2,6-dicarboxamide
C21H19N3O4
Acta Crystallographica Section E (2001) 57, 12 o1161-o1162
a=4.7919(9)Å b=15.775(3)Å c=25.228(5)Å
α=90.00° β=90.00° γ=90.00°
N-(4-methoxylphenyl)quinoline-2-carboxamide
C17H14N2O2
Acta Crystallographica Section E (2003) 59, 1 o102-o103
a=6.6372(11)Å b=18.109(3)Å c=11.4921(19)Å
α=90.00° β=92.867(3)° γ=90.00°
N-(4-iodopheny)quinoline-2-carboxamide
C16H11IN2O
Acta Crystallographica Section E (2003) 59, 1 o104-o105
a=6.5389(10)Å b=17.036(3)Å c=12.702(2)Å
α=90.00° β=102.377(3)° γ=90.00°
Tetrabutylammonium bis[N,N'-bis(4-chlorophenyl)pyridine-2,6-dicarboxamide(1-)]cobalt(III) monohydrate
(C16H36N),(C38H22Cl4CoN6O4),H2O
Acta Crystallographica Section E (2007) 63, 1 m159-m161
a=12.9275(17)Å b=24.350(3)Å c=18.267(2)Å
α=90.00° β=110.154(3)° γ=90.00°
Tris[N-(4-fluorophenyl)pyridine-2-carboxamide-κ^2^N,N]cobalt(III)
C36H24CoF3N6O3,3(H2O)
Acta Crystallographica Section C (2004) 60, 5 m210-m211
a=12.1443(12)Å b=12.2258(12)Å c=14.5543(14)Å
α=99.774(2)° β=103.547(2)° γ=117.775(2)°
(R)-(6,6'-dihydroxybiphenyl-2,2'-diyl)bis(diphenylphosphine oxide)
C36H28O4P2,CH4O
Acta Crystallographica Section C (2003) 59, 1 o33-o35
a=9.9351(16)Å b=11.1490(17)Å c=27.977(4)Å
α=90° β=90° γ=90°